- 1.
Lai, Y.C. ;Potoka, K.C. ;Champion, H.C. ; et al . Pulmonary arterial hypertension: the clinical syndrome . Circ. Res. , 2014 , 115 ( 1 ): 115 - 130 .
- 2.
Spiekerkoetter, E. ;Kawut, S.M. ;de Jesus Perez, V . A . New and Emerging Therapies for Pulmonary Arterial Hypertension. Annu. Rev. Med. , 2019 , 70 : 45 - 59 .
- 3.
Humbert, M. ;Kovacs, G. ;Hoeper, M.M. ; et al . 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension . Eur. Heart J. , 2022 , 43 ( 38 ): 3618 - 3731 .
- 4.
Guignabert, C. ;Tu, L. ;Girerd, B. ; et al . New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication . Chest , 2015 , 147 ( 2 ): 529 - 537 .
- 5.
Evans, C.E. ;Cober, N.D. ;Dai, Z. ; et al . Endothelial cells in the pathogenesis of pulmonary arterial hypertension . Eur. Respir. J. , 2021 , 58 ( 3 ): 2003957 .
- 6.
He, Y.Y. ;Xie, X.M. ;Zhang, H.D. ; et al . Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension . Front. Pharmacol. , 2021 , 12 : 753727 .
- 7.
Tajsic, T. ;Morrell, N . W . Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. Compr. Physiol. , 2011 , 1 ( 1 ): 295 - 317 .
- 8.
Wang, S. ;Yan, Y. ;Xu, W.J. ; et al . The Role of Glutamine and Glutaminase in Pulmonary Hypertension . Front. Cardiovasc. Med. , 2022 , 9 : 838657 .
- 9.
Yan, Y. ;He, Y.Y. ;Jiang, X. ; et al . DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension . Sci. Adv. , 2020 , 6 ( 50 ): eaba2470 .
- 10.
He, Y.Y. ;Yan, Y. ;Jiang, X. ; et al . Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension . Eur. Respir. J. , 2020 , 56 ( 5 ): 2000522 .
- 11.
He, Y.Y. ;Yan, Y. ;Chen, J.W. ; et al . Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease . Acta. Pharmacol. Sin. , 2022 , 43 ( 7 ): 1710 - 1720 .
- 12.
Wu, X.H. ;He, Y.Y. ;Chen, Z.R. ; et al . Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype . Nat. Commun. , 2023 , 14 ( 1 ): 1820 .
- 13.
Ruopp, N.F. ;Cockrill, B . A . Diagnosis and Treatment of Pulmonary Arterial Hypertension : A Review. J.A.M.A. , 2022 , 327 ( 14 ): 1379 - 1391 .
- 14.
Humbert, M. ;McLaughlin, V. ;Gibbs, J . S .R.; et al. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. N. Engl. J. Med. , 2021 , 384 ( 13 ): 1204 - 1215 .
- 15.
Jiang, M. ;Sheng, F. ;Zhang, Z. ; et al . Andrographis paniculata (Burm.f.) Nees and its major constituent andrographolide as potential antiviral agents . J. Ethnopharmacol. , 2021 , 272 : 113954 .
- 16.
Chua, L . S . Review on liver inflammation and antiinflammatory activity of Andrographis paniculata for hepatoprotection. Phytother. Res. , 2014 , 28 ( 11 ): 1589 - 1598 .
- 17.
Peng, Y. ;Wang, Y. ;Tang, N. ; et al . Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway . J. Exp. Clin. Cancer Res. , 2018 , 37 ( 1 ): 248 .
- 18.
Dai, Y. ;Chen, S.R. ;Chai, L. ; et al . Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide . Crit. Rev. Food Sci. Nutr. , 2019 , 59 ( sup1 ): S17 - S29 .
- 19.
Burgos, R.A. ;Alarcón, P. ;Quiroga, J. ; et al . Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism . Molecules , 2020 , 26 ( 1 ): 5 .
- 20.
Tohkayomatee, R. ;Reabroi, S. ;Tungmunnithum, D. ; et al . Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling . Molecules , 2022 , 27 ( 11 ): 3544 .
- 21.
Dai, L. ;Wang, G. ;Pan, W . Andrographolide Inhibits Proliferation and Metastasis of SGC7901 Gastric Cancer Cells . Biomed. Res. Int. , 2017 , 2017 : 6242103 .
- 22.
Bisserier, M. ;Mathiyalagan, P. ;Zhang, S. ; et al . Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension . Circulation , 2021 , 144 ( 1 ): 52 - 73 .
- 23.
Zhang, Y. ;Peng, B. ;Han, Y . MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling . Biomed Pharmacother , 2018 , 103 : 1279 - 1286 .
- 24.
Barberà, J.A. ;Román, A. ;Gómez-Sánchez, M.Á. ; et al . Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations . Arch. Bronconeumol (Engl Ed). , 2018 , 54 ( 4 ): 205 - 215 .
- 25.
Peng, G. ;Xu, J. ;Liu, R. ; et al . Isolation, culture and identification of pulmonary arterial smooth muscle cells from rat distal pulmonary arteries . Cytotechnology , 2017 , 69 ( 5 ): 831 - 840 .
- 26.
Yan, Y. ;Jiang, R. ;Yuan, P. ; et al . Implication of proliferation gene biomarkers in pulmonary hypertension . Animal Model. Exp. Med. , 2021 , 4 ( 4 ): 369 - 380 .
- 27.
Woo, K.V. ;Shen, I.Y. ;Weinheimer, C.J. ; et al . Endothelial FGF signaling is protective in hypoxia-induced pulmonary hypertension . J. Clin. Invest. , 2021 , 131 ( 17 ): e141467 .
- 28.
Langleben, D. ;Orfanos, S.E. ;Fox, B.D. ; et al . The Paradox of Pulmonary Vascular Resistance: Restoration of Pulmonary Capillary Recruitment as a Sine Qua Non for True Therapeutic Success in Pulmonary Arterial Hypertension . J. Clin. Med. , 2022 , 11 ( 15 ): 4568 .
- 29.
White, R.J. ;Meoli, D.F. ;Swarthout, R.F. ; et al . Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension . Am. J. Physiol. Lung Cell. Mol. Physiol. , 2007 , 293 ( 3 ): L583 - 90 .
- 30.
Fan, Y. ;Gu, X. ;Zhang, J. ; et al . TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2 . Am. J. Respir. Crit. Care Med. , 2020 , 202 ( 9 ): 1283 - 1296 .
- 31.
Jiaqi, L. ;Siqing, H. ;Qin, W. ; et al . Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction . Phytomedicine , 2023 , 109 : 154601 .
- 32.
Chou, Y.J. ;Lin, C.C. ;Hsu, Y.C. ; et al . Andrographolide suppresses the malignancy of triple-negative breast cancer by reducing THOC1-promoted cancer stem cell characteristics . Biochem. Pharmacol. , 2022 , 206 : 115327 .
- 33.
Janani, B. ;Vijayakumar, M. ;Priya, K. ; et al . A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer . Front. Pharmacol. , 2022 , 13 : 967262 .
- 34.
Lu, Q.B. ;Wan, M.Y. ;Wang, P.Y. ; et al . Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade . Redox. Biol. , 2018 , 14 : 656 - 668 .